AnGes Inc (AMGXF)
0.4087
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
AnGes Net Income (Quarterly): -24.62M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -24.62M |
| June 30, 2024 | -10.75M |
| March 31, 2024 | -12.29M |
| December 31, 2023 | -17.88M |
| September 30, 2023 | 0.2202M |
| June 30, 2023 | -13.98M |
| March 31, 2023 | -22.04M |
| December 31, 2022 | -32.06M |
| September 30, 2022 | -20.04M |
| June 30, 2022 | -34.63M |
| March 31, 2022 | -25.29M |
| December 31, 2021 | -15.15M |
| September 30, 2021 | -40.91M |
| June 30, 2021 | -37.78M |
| March 31, 2021 | -31.29M |
| December 31, 2020 | -9.908M |
| September 30, 2020 | -12.05M |
| June 30, 2020 | -9.070M |
| March 31, 2020 | -8.448M |
| December 31, 2019 | -9.014M |
| September 30, 2019 | -7.430M |
| June 30, 2019 | -7.187M |
| March 31, 2019 | -10.75M |
| December 31, 2018 | -7.042M |
| September 30, 2018 | -9.469M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.594M |
| March 31, 2018 | -4.956M |
| December 31, 2017 | -3.589M |
| September 30, 2017 | -9.553M |
| June 30, 2017 | -7.092M |
| March 31, 2017 | -13.30M |
| December 31, 2016 | -8.731M |
| September 30, 2016 | -9.756M |
| June 30, 2016 | -14.77M |
| March 31, 2016 | -10.68M |
| December 31, 2015 | -9.348M |
| September 30, 2015 | -7.920M |
| June 30, 2015 | -9.530M |
| March 31, 2015 | -7.419M |
| December 31, 2014 | -2.436M |
| September 30, 2014 | -10.79M |
| June 30, 2014 | -5.187M |
| March 31, 2014 | -4.268M |
| December 31, 2013 | -4.360M |
| September 30, 2013 | -3.230M |
| June 30, 2013 | -2.894M |
| March 31, 2013 | -3.981M |
| December 31, 2012 | -5.683M |
| September 30, 2012 | -4.488M |
| June 30, 2012 | -5.508M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-40.91M
Minimum
Sep 2021
0.2202M
Maximum
Sep 2023
-19.35M
Average
-16.51M
Median
Net Income (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 619.69M |
| Nxera Pharma Co Ltd | 8.079M |
| PeptiDream Inc | 120.39M |
| Healios KK | -3.426M |
| SanBio Co Ltd | -7.409M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.8352M |
| Total Expenses (Quarterly) | 13.86M |
| EPS Diluted (Quarterly) | -0.1057 |
| Enterprise Value | 86.92M |
| Gross Profit Margin (Quarterly) | 31.07% |
| Profit Margin (Quarterly) | -2.95K% |
| Earnings Yield | -75.18% |
| Normalized Earnings Yield | -60.23 |